IPP Bureau
OneSource Specialty Pharma appoints Jeffrey Wong as CBO
By IPP Bureau - July 08, 2025
He has held senior leadership positions at Syngene International, Fujifilm Diosynth Biotechnologies, Thermo Fisher Scientific, Sartorius Stedim Biotech, and other leading organizations
Duke Street Bio receives FDA fast track designation for PARP1-selective inhibitor with CNS activity
By IPP Bureau - July 08, 2025
Addresses brain metastases harboring BRCA1/2 and/or HRR alterations—an area of high unmet need
AB Science receives FDA and EMA authorization for phase 3 Trial of prostate cancer treatment
By IPP Bureau - July 08, 2025
Masitinib is targeted at patients who are no longer responding to hormone-sensitive prostate cancer treatments
Everest Medicines progresses in AI-powered mRNA platform at 2025 R&D day
By IPP Bureau - July 08, 2025
The company showcased three core programs developed through this platform
EMA and HMA to strengthen Anti-D Immunoglobulin supply chain
By IPP Bureau - July 08, 2025
These medicines are essential in preventing RhD immunisation during pregnancy
Veerhealth Care enters into contract manufacturing agreement
By IPP Bureau - July 08, 2025
Commercial production is expected to begin soon
Godavari Biorefineries' anti-cancer patent now validated in Spain and UK
By IPP Bureau - July 07, 2025
Anti-cancer patent now validated in Spain, the UK, and as a Unitary Patent covering multiple EU member states
Dr. Jitendra Singh inaugurates 'National Biobank' at CSIR-IGIB
By IPP Bureau - July 07, 2025
CSIR-IGIB advances indigenous CRISPR Trials on sickle cell anaemia, anti-microbial resistance, liver fibrosis and rare disorders
Biocon Biologics receives MHRA UK approval for Vevzuo and Evfraxy, Denosumab Biosimilars
By IPP Bureau - July 07, 2025
Vevzuo is authorized for the prevention of skeletal related events in adults with advanced malignancies involving bone
Sigachi Industries appoints Lijo Stephen Chacko as Deputy Group CEO
By IPP Bureau - July 07, 2025
Lijo Chacko is the Chief Executive Officer – Middle East & Africa at Sigachi Industries
SPARC incorporates subsidiary ‘Genokine Biotech’
By IPP Bureau - July 07, 2025
The wholly owned subsidiary will carry on the business of all types of research and development and other related services
GACL flags of first dispatch of Benzyl Alcohol and Benzaldehyde
By IPP Bureau - July 06, 2025
The facility will manufacture 13,200 MTPA Benzyl Chloride, 9,600 MTPA Benzyl Alcohol, and 7,200 MTPA Benzaldehyde
Shilpa Pharma Lifesciences Unit-1 inspected by ANVISA
By IPP Bureau - July 06, 2025
The audit has been concluded with no major observations















